COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

View Details

Agenda

 

Thursday, September 22, 2022

7:00 am Registration & Continental Breakfast
8:00 am
Welcome & Introductions, Ezra Cohen, MD & Liza Blumenfeld, MA, CCC-SLP, BCS-S
8:10 am
Immunotherapy: Where are We In 2022? Ezra Cohen, MD
8:30 am
State of the Art Management of Swallowing Impairment Associated with Radiation Peter Belafsky, MD, MPH, PhD
8:50 am
​Optimizing Therapeutic Vaccination Against Natural Neoantigens, Stephen Schoenberger, PhD 
9:10 am QUASAR, Liza Blumenfeld, MA, CCC-SLP, BCS-S
9:30 am
Break & Visit Exhibitors

 

Concurrent Session
New Horizons

Concurrent Session 
Multidisciplinary HNC Management

New Horizons Session 1 -Adaptive Neoadjuvant Designs/Approaches

 Multidisciplinary Care Session 1
10:00 am Using Neoadjuvant Designs To Develop Precision Immunotherapy, Robert Ferris, MD
10:00 am
FEES: Moving Towards Objective Analysis, Kate Hutcheson, PhD
10:15 am NIRT – Not Just Neoadjuvant IO Bryan Bell, MD
10:20 am The Hail Mary: A Laryngologist’s Perspective, Philip Weissbrod, MD
10:30 am Enhancing Systemic Anti-Tumor Immunity with Neoadjuvant Immunotherapy for HPV Unrelated HNSCC, Clint T. Allen, MD
10:40 am Immunotherapy: What’s All the Fuss? Assuntina G. Sacco, MD
10:45 am
Panel Discussion
11:00 am To Have and to Hold: Committing to the Electrolarynx Kristen Linnemeyer, MA, CCC-SLP, BCS-S

Predictive Assays/Preclinical Models
11:20 am Putting the Pieces Back Together: How to Maximize Function After
Reconstructive Surgery,
Ryan Orosco, MD
11:00 am Immunocompetent mouse models of HNSCC, J. Silvio Gutkind, PhD11:40 am
It’s not all black and white: Using imaging data to plan and execute the head and neck cancer plan of care, Julie Bykowski, MD
11:15 am RNA Splice Variants, Theresa Guo, MD

11:30 am Somatic copy-number loss at 9p21 triggers an immune-cold 'switch' and -checkpoint-inhibitor resistance in HPV— head and neck cancer,Scott M. Lippman, MD 

11:45 am
Panel Discussion
12:00 pm
Lunch
New Horizons Session 2 - Cellular Therapy Multidisciplinary Care Session 2
1:00 pm

Isolating/Expanding the Entire TIL Repertoire of Tumor-Reactive CD8 T Cells for Cell Therapy in H&N Cancer, Andrew D. Weinberg, MD

1:00 pm
What the Hexia is Cachexia?
Traci Roberts, RD, MBA
1:20 pm TILs Update, Eric Tran, PhD
1:20 pm Xerostomia: Spit Matters!
Charles Coffey, MD
1:40 pm TCR-T Cells in HNSCC, Christian S. Hinrichs, MD
1:40 pm Electrons and Photons and Protons, Oh My! Loren Mell, MD
2:00 pm Discussion
 2:00 pm The Mentor and Mentee Experience in TEP Management, Liza Blumenfeld, MA, CCC-S, Kristen Linnemeyer, MA, CCC-SLP, BCS-S
2:30 pm Break / Vendors
3:00 pm Multidisciplinary Tumor Board, Faculty
3:45 pm Can you hear my voice?, Bill Brummel
4:00 pm
 Reception
5:30 pm
Adjourn

 

Friday, September 23, 2022

​7:30 am
​Registration & Continental Breakfast
​8:00 am​The Great Debate
  1. The Unresectable Local Recurrence – reRT or IO?, Nancy Lee, MD vs. Dan P. Zandberg, MD
  2. G-tube Removal in the Setting of Severe Oropharyngeal Dysphagia, Andrew Vahabzadeh-Hagh, MD vs. Erin Walsh, MA, CCC-SLP, IBCLC, BCS-S 
  3. Surgery vs CRT in Early Stage HPV-mediated Head and Neck Cancer, Loren Mell, MD vs. Kevin T. Brumund, MD
​9:00 am
​​Break/Vendors

​Concurrent Sessions                         New Horizons

Concurrent Sessions                          Multidisciplinary HNC Management 


​New Horizons Session 3 - IO + RT ​​ Multidisciplinary Care Session 3
​9:20 am    Radionuclide Therapy and Immune Checkpoint Blockade, Ravi Patel, MD, PhD ​​9:20 am     ​Dysphagia is a Symptom not a Disease, Peter Belafsky, MD, MPH, PhD
​9:40 am   ​Wait a Minute – B cells?
Andrew Sharabi, MD, PhD		​9:40 am   ​Risk Factors and Management of Late-Radiation Associated Dysphagia
Kate Hutcheson, PhD
​10:00 am   
​Thinking Beyond PD-1 for Radiation Combinatorial Therapy, Heath D. Skinner, MD, PhD10:00 am    ​Lymphedema Management Across the Care Continuum, Alyssa Shelton, MA, OT​
​10:20 am  
​Panel Discussion​10:20 am  
​Leveling up: Raising the standards on objective assessment, Andi Docktor, MA, CCC-SLP
​10:40 am   ​Break / Vendors ​ ​
​New Horizons Session 4 - New Diseases, Thyroid & Cutaneous ​​​
​11:00 am  
​Cutaneous SCC, Gregory A. Daniels, MD, PhD​11:00 am ​Shedding Light on the Unseen: The Mental, Emotional and Social Sequelae of Head and Neck Cancer
Liza Blumenfeld, MA, CCC-SLP, BCS-S,
Kristen Linnemeyer, MA, CCC-SLP,   BCS-S
Heather Starmer, MA CCC-SLP, BCS-S
Lisa Evangelista. CScD, CCC-SLP, BCS-S



​11:15 am    ​New Targets – RET/NTRK
Lori J. Wirth, MD		12:00 pm
Adjourn
​11:30 am  ​IO in Thyroid Cancer
Matthew Taylor, MD		​​
​11:45 am
​Panel Discussion
​​
​12:00 pm
​Lunch on your own
​​
​New Horizons Session 5 - New Targets ​​​
​1:00 pm   ​The Development and Dynamics of Pre-existing immunity in tumors, Michael J. Gough, PhD​​
​1:20 pm   
​Bioactive Lipid Metabolites Regulate Clinical Response to Immune Checkpoint Blockade, Sonia Sharma, PhD 
​​
​1:40 pm    
​The Role of the Sentinel Node in Response to Immunoradiotherapy, Joseph Califano, MD ​​
​2:00 pm​Metabolic Barriers and T Cell Exhaustion in the TME, Dayana Rivadeneira, PhD
​
​
​2:20 pm   The Critical Role of TME in Head and Neck Cancer, Judith Varner, MD
​​
​2:40 pm    ​Panel Discussion​​
​3:00 pm
​Final Adjournment
​​


Show additional content areas below